| Alliance Hospice Of Idaho 1270 South Woodruff, Idaho Falls, ID, 83404 | |
| (208) 733-2234 |
News Archive
Eagle Pharmaceuticals, Inc. today announced the U. S. Food and Drug Administration (FDA) has approved Ryanodex® (dantrolene sodium) for injectable suspension indicated for the treatment of malignant hyperthermia (MH), along with the appropriate supportive measures.
Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types of tumor respond well to treatment, others such as glioblastomas - the most common and aggressive brain tumors - are known to recur and progress within short times from the diagnosis.
Many women and clinicians worry that taking combination hormonal contraceptives will result in weight gain.
Federal data shows that doctors and other health care professionals made more than $212 million in speaking and consulting for drug and device makers in the five months at the end of last year, reports The New York Times.
› Verified 1 days ago
| Name | Alliance Hospice Of Idaho |
|---|---|
| Location | 1270 South Woodruff, Idaho Falls, Idaho |
| Hospice ID | 131544 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Other |
| Profit Type | FOR PROFIT |
| SSA county code | 090 |
News Archive
Eagle Pharmaceuticals, Inc. today announced the U. S. Food and Drug Administration (FDA) has approved Ryanodex® (dantrolene sodium) for injectable suspension indicated for the treatment of malignant hyperthermia (MH), along with the appropriate supportive measures.
Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types of tumor respond well to treatment, others such as glioblastomas - the most common and aggressive brain tumors - are known to recur and progress within short times from the diagnosis.
Many women and clinicians worry that taking combination hormonal contraceptives will result in weight gain.
Federal data shows that doctors and other health care professionals made more than $212 million in speaking and consulting for drug and device makers in the five months at the end of last year, reports The New York Times.
› Verified 1 days ago
| NPI Number | 1144363078 |
| Organization Name | Northwest Bel-corp |
| Address | 1440 Filer Avenue East Twin Falls, Idaho, 83301 |
| Phone Number | (208)733-2234 |
News Archive
Eagle Pharmaceuticals, Inc. today announced the U. S. Food and Drug Administration (FDA) has approved Ryanodex® (dantrolene sodium) for injectable suspension indicated for the treatment of malignant hyperthermia (MH), along with the appropriate supportive measures.
Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types of tumor respond well to treatment, others such as glioblastomas - the most common and aggressive brain tumors - are known to recur and progress within short times from the diagnosis.
Many women and clinicians worry that taking combination hormonal contraceptives will result in weight gain.
Federal data shows that doctors and other health care professionals made more than $212 million in speaking and consulting for drug and device makers in the five months at the end of last year, reports The New York Times.
› Verified 1 days ago
| NPI Number | 1467772897 |
| Organization Name | Alliance Home Health Of Idaho, Llc |
| Address | 218 Falls Ave Twin Falls, Idaho, 83301 |
| Phone Number | (208)733-2234 |
News Archive
Eagle Pharmaceuticals, Inc. today announced the U. S. Food and Drug Administration (FDA) has approved Ryanodex® (dantrolene sodium) for injectable suspension indicated for the treatment of malignant hyperthermia (MH), along with the appropriate supportive measures.
Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types of tumor respond well to treatment, others such as glioblastomas - the most common and aggressive brain tumors - are known to recur and progress within short times from the diagnosis.
Many women and clinicians worry that taking combination hormonal contraceptives will result in weight gain.
Federal data shows that doctors and other health care professionals made more than $212 million in speaking and consulting for drug and device makers in the five months at the end of last year, reports The New York Times.
› Verified 1 days ago
| NPI Number | 1699228403 |
| Organization Name | S&g Hospice Of Idaho Llc |
| Address | 1270 S Woodruff Ave Idaho Falls, Idaho, 83404 |
| Phone Number | (208)552-0249 |
News Archive
Eagle Pharmaceuticals, Inc. today announced the U. S. Food and Drug Administration (FDA) has approved Ryanodex® (dantrolene sodium) for injectable suspension indicated for the treatment of malignant hyperthermia (MH), along with the appropriate supportive measures.
Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types of tumor respond well to treatment, others such as glioblastomas - the most common and aggressive brain tumors - are known to recur and progress within short times from the diagnosis.
Many women and clinicians worry that taking combination hormonal contraceptives will result in weight gain.
Federal data shows that doctors and other health care professionals made more than $212 million in speaking and consulting for drug and device makers in the five months at the end of last year, reports The New York Times.
› Verified 1 days ago
| NPI Number | 1730294463 |
| Organization Name | Hospice Alliance Of Idaho, Llc |
| Address | 1270 S Woodruff Ave Idaho Falls, Idaho, 83404 |
| Phone Number | (208)552-0249 |
News Archive
Eagle Pharmaceuticals, Inc. today announced the U. S. Food and Drug Administration (FDA) has approved Ryanodex® (dantrolene sodium) for injectable suspension indicated for the treatment of malignant hyperthermia (MH), along with the appropriate supportive measures.
Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types of tumor respond well to treatment, others such as glioblastomas - the most common and aggressive brain tumors - are known to recur and progress within short times from the diagnosis.
Many women and clinicians worry that taking combination hormonal contraceptives will result in weight gain.
Federal data shows that doctors and other health care professionals made more than $212 million in speaking and consulting for drug and device makers in the five months at the end of last year, reports The New York Times.
› Verified 1 days ago
| NPI Number | 1992945653 |
| Organization Name | Brp Health Management Systems Inc |
| Address | 1440 Filer Ave E Twin Falls, Idaho, 83301 |
| Phone Number | (208)733-2234 |
News Archive
Eagle Pharmaceuticals, Inc. today announced the U. S. Food and Drug Administration (FDA) has approved Ryanodex® (dantrolene sodium) for injectable suspension indicated for the treatment of malignant hyperthermia (MH), along with the appropriate supportive measures.
Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types of tumor respond well to treatment, others such as glioblastomas - the most common and aggressive brain tumors - are known to recur and progress within short times from the diagnosis.
Many women and clinicians worry that taking combination hormonal contraceptives will result in weight gain.
Federal data shows that doctors and other health care professionals made more than $212 million in speaking and consulting for drug and device makers in the five months at the end of last year, reports The New York Times.
› Verified 1 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
| Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
Eagle Pharmaceuticals, Inc. today announced the U. S. Food and Drug Administration (FDA) has approved Ryanodex® (dantrolene sodium) for injectable suspension indicated for the treatment of malignant hyperthermia (MH), along with the appropriate supportive measures.
Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types of tumor respond well to treatment, others such as glioblastomas - the most common and aggressive brain tumors - are known to recur and progress within short times from the diagnosis.
Many women and clinicians worry that taking combination hormonal contraceptives will result in weight gain.
Federal data shows that doctors and other health care professionals made more than $212 million in speaking and consulting for drug and device makers in the five months at the end of last year, reports The New York Times.
› Verified 1 days ago
| Home Health Aides | 2 |
| Licensed Practical or Vocational Nurses | 1 |
| Medical Social Workers | 2 |
| Registered Nurses | 4 |
| Other Personnel | 2 |
| Total Employees | 11 |
|---|
News Archive
Eagle Pharmaceuticals, Inc. today announced the U. S. Food and Drug Administration (FDA) has approved Ryanodex® (dantrolene sodium) for injectable suspension indicated for the treatment of malignant hyperthermia (MH), along with the appropriate supportive measures.
Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types of tumor respond well to treatment, others such as glioblastomas - the most common and aggressive brain tumors - are known to recur and progress within short times from the diagnosis.
Many women and clinicians worry that taking combination hormonal contraceptives will result in weight gain.
Federal data shows that doctors and other health care professionals made more than $212 million in speaking and consulting for drug and device makers in the five months at the end of last year, reports The New York Times.
› Verified 1 days ago
| Hospice Of Eastern Idaho Location: 1810 Moran Street, Idaho Falls, Idaho, 83401 Phone: (208) 733-2234 |
| Aspen Hospice Location: 3470 Washington Parkway, Suite B, Idaho Falls, Idaho, 83404 Phone: (208) 733-2234 |
| Alliance Hospice Of Idaho Location: 1270 South Woodruff, Idaho Falls, Idaho, 83404 Phone: (208) 733-2234 |
| Hands Of Hope Hospice Location: 1379 East 17th Street, Idaho Falls, Idaho, 83401 Phone: (208) 733-2234 |